Chemist + Druggist is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


GPhC: Delayed registration exam to take place in early 2021

The rescheduled 2020 registration exam will be held in the first quarter of 2021, the General Pharmaceutical Council (GPhC) has announced.

The assessment will not take place in the first two weeks of January, and although the GPhC has not yet identified an “exact date” for the exam, it has now found a “preferred supplier”.

The regulator will collaborate with the supplier to set a date, GPhC director of education and standards Mark Voce said in an update to candidates yesterday (September 30).

The regulator will work with its appointed supplier to decide “how and when to start the application process, adjustment arrangements and the assessment specification”, Mr Voce added.

Candidates can expect further updates later this month, he said.

“Earliest feasible time”

Mr Voce apologised to the graduates who wished to sit the exam at an earlier date.

“This is the earliest feasible time to hold the assessment, as we need to carry out extensive testing to make sure that the online registration assessment will work well for all candidates,” he said.

The GPhC – which is currently in “contractual discussions” with the provider it has identified – will need to test its systems for “verifying identity, invigilating the sitting and providing adjustments to candidates”, Mr Voce added

More information on the assessment will be shared with candidates “as soon as it is available, including through a webinar”.

Provisionally registered pharmacists and pre-registration trainees were encouraged to look at “the example questions and learning points from previous sittings” as the topics in the exam and the standards required to pass will remain the same.

The GPhC’s announcement generated mixed feelings on social media, with some arguing that the exam should be scrapped altogether.

Others said the exam is needed to maintain professional standards and that the 2021 exam date gives candidates plenty of time to prepare.

Commenting on the GPhC’s update, Royal Pharmaceutical Society (RPS) director of education Gail Fleming said that “it’s very disappointing that after all this time, the GPhC is still unable to provide trainees with a definite date for the delayed assessment".

"We urge the GPhC to act quickly to set an exact date to provide certainty to those who will be sitting the exam," she added.

On March 26, the GPhC announced that it had decided to postpone the 2020 registration assessments due to COVID-19. In May, it told C+D that the pandemic had accelerated existing plans to move to an online registration assessment.

Following a request for an update on the registration assessment from the RPS and the British Pharmaceutical Students’ Association last month (September 18), the GPhC responded that it was unable to confirm an exact date for the exam until it had appointed a provider.

There are more than 2,200 people on the GPhC’s provisional register. In order to remain on the register, they will have to pass the registration assessment “at the first opportunity if they are fit to do so”.

Do you think the GPhC exam should be held before 2021?

Related Content


Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts